Results 121 to 130 of about 8,597,475 (170)

Infographic: study design of the QUASAR randomised trial of aflibercept 8 mg in retinal vein occlusion

Eye
Andrew Chang, Sergio Leal, Lynne Brunck, Alyson J. Berliner, Fabiana Silva   +4 more
openaire   +2 more sources

New Clinical Trials and Therapeutic Advances with Faricimab and Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration: A Durability-Oriented Comparative Perspective. [PDF]

Biomedicines
Menna F, De Luca L, Meduri A, Baldascino A, Lupo S, Vingolo EM.   +5 more
europepmc   +1 more source

Letter to the Editor Regarding "Aflibercept 8 mg versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials". [PDF]

Ophthalmol Ther
Panos GD.
europepmc   +1 more source

Effect of Key Baseline Disease Characteristics on Aflibercept 8 mg Dosing Interval Extension

Ophthalmology Retina
Justus G. Garweg, Varun Chaudhary, Xin Zhang, Sergio Leal, Tobias Machewitz, Marion R. Munk, Javier Zarranz-Ventura, Andreas Stahl, Paolo Lanzetta, Patricio Schlottmann, Tamara Zompa, Arturo Alezzandrini, Andrew Chang, Jennifer Arnold, Samantha Fraser-Bell, Alan Luckie, Nitin Verma, Yosuf El-Shabrawi, Peter Reinelt, Oliver Findl, Anton Haas, Matthias Bolz, Veselin Daskalov, Daniela Mitova, Hristina Blagoeva, Hristina Grupcheva, Aleksandar Oscar, Iva Petkova, Andrei Andreev, Petya Vasileva, Thomas Sheidow, Keyvan Koushan, Louis-Pierre Gauvin, Xiaodong Sun, Mingchang Zhang, Ke Fan, Xueyi Chen, Mei HAN, Hong Dai, Jun Xiao, Wenhui Yang, Xufang Sun, Xiaoling Liu, Shaoping Ha, Jing Lin Zhang, Qiong Zhou, Xuguang Sun, Xiaofeng Li, Yalin He, Ling Xu, Liu Yang, Miaoqin Wu, Jianping Tong, Jian Guo, Libo Ma, Yi Wang, Wenbin Wei, Mingwei Zhao, Xiaorong Li, Cheng Pei, Liming Tao, Suyan Li, Lifei Wang, Yanlong Bi, Xu Qiu, Qian Ren, Jan Ernest, Jan Nemcansky, Jan Studnicka, Miroslav Veith, Jan Hamouz, Martin Choleva, Hana Fidranska, Oldrich Chrapek, Kai Noor, Katrin Hannus, Kuldar Kaljurand, Eric Souied, Ramin Tadayoni, Laurent Kodjikian, François Devin, Hessam Razavi, Hélène Massé, Marina Ramazashvili, George Chichua, Mikheil Omiadze, Jakob Jikia, György Bátor, Ágnes Kerényi, András Seres, András Papp, Edit Toth-Molnar, Attila Vajas, Balázs Varsányi, Gábor Vogt, Tibor Milibák, Norbert Czumbel, Elad Moisseiev, Eva Platner, Shiri Shulman, Eva Eting, David Hauser, Nurit Mathalone, Yoreh Barak, Haia Morori-Kats, Tareq Jaouni, Daniele Tognetto, Francesco Bandello, Federico Ricci, Monica Varano, Carlo Cagini, Teresio Avitabile, Enrico Peiretti, Angelo Maria Minnella, Giovanni Staurenghi, Akiko Miki, Hideyasu Oh, Ken Hayashi, Tatsuya Fujisaki, Tsutomu Yasukawa, Tetsuju Sekiryu, Tetsuo Ueda, Yuki Morizane, Hideki Koizumi, Shigeo Yoshida, Masahito Ohji, Hisashi Matsubara, Takeshi Iwase, Yasuo Ito, Jun Takeuchi, Kanji Takahashi, Yosuke Harada, Kazuhiro Kimura, Hideki Kataoka, Toru Noda, Hitoshi Ono, Daisuke Takemoto, Kazuhiko Dannoue, Yoshinori Mitamura, Kenichi Kimoto, Genichiro Kishino, Hidetoshi Takahashi, Ryo Obata, Yoichi Sakurada, Yoshihito Sakanishi, Toshinori Murata, Tetsuya Nishimura, Ai Yoneda, Hiroshi Sasaki, Hiroshi Otake, Shigeru Honda, Keiichi Mitarai, Shunji Kusaka, Kyoko Fujita, Kiyoshi Ishii, Yasuhiro Ikeda, Yoko Ozawa, Hajime Shinoda, Kimimasa Muranaka, Ken Ogino, Kiyoshi Suzuma, Toshio Okanouchi, Hideo Akiyama, Namie Kobayashi, Tomohiro Iida, Katsuhiro Nishi, Hiroki Tanaka, Hiroko Imaizumi, Jiro Kogo, Kanako Yasuda, Tomoko Noda, Iksoo Byon, Young Hee Yoon, Se Woong Kang, Eun Kyoung Lee, Se Joon Woo, Mihyun Choi, Hyun Woong Kim, Won Ki Lee, Indars Lacis, Guna Laganovska, Kristine Baumane, Jurate Balciuniene, Andrius Cimbalas, Jurgita Kazlauskaite, Rufino Martins da Silva, Carlo Neves, Miguel Lume, Luis Silva, Joao Figueira, Maria Budzinskaya, Boris Malyugin, Andrey Zolotarev, Tatiana Yurieva, Miroslav Stamenkovic, Dijana Risimic, Sinisa Babovic, Caroline Chee, Chui Ming Gemmy Cheung, Karen Jhi Wen Chia   +199 more
openaire   +1 more source

A Response to: Letter to the Editor Regarding "Aflibercept 8 mg Versus Faricimab Treat-and-Extend for Diabetic Macular Edema or Neovascular Age-Related Macular Degeneration: A Bayesian Fixed-Effect Network Meta-analysis of Clinical Trials". [PDF]

Ophthalmol Ther
Friedman SM, Xu Y, Sherman S, Kuznik A, Mojebi A, Keeping S, Chan K, Leng T, Patel N.   +8 more
europepmc   +1 more source

Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study. [PDF]

J Clin Med
Funatsu M, Higashijima F, Ariyoshi N, Haraguchi A, Wasai Y, Mikuni M, Ohta M, Wakuta M, Hirano S, Yamauchi K, Kimura K.   +10 more
europepmc   +1 more source

Twelve-Month Outcomes Using Aflibercept 8 mg in Treatment-Naïve and Pretreated Diabetic Macular Edema: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Sci
Spindler J, Artemiev D, Pfister IB, Schild C, Tillmann A, Heck K, Gabathuler F, Ruscitti L, Spitznagel T, Kitsos-Kalyvianakis K, Munk MR, Hatz K, Zweifel SA, Grimaldi G, Somfai GM, Ambresin A, Weinberger A, Eandi CM, Feltgen N, Kitay A, Ebneter A, Garweg JG.   +21 more
europepmc   +1 more source

One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. [PDF]

Ophthalmol Ther
Kitay AM, Tillmann A, Pfister I, Schild C, Bonanata M, Heck K, Spitznagel T, Gabathuler F, Bartolomeo N, Magnin S, Löliger J, Munk MR, Menghini M, Hatz K, Somfai GM, Zweifel S, Ambresin A, Eandi CM, Feltgen N, Weinberger A, Garweg JG, Kurz-Levin MM.   +21 more
europepmc   +1 more source

Multiple retinal vein thrombi after an intravitreal aflibercept 8 mg injection for age-related macular degeneration

Eye
Masatoshi Haruta, Shotaro Dake, Shigeo Yoshida   +2 more
openaire   +2 more sources